Where is NBE Therapeutics headquartered?

NBE Therapeutics is located in Basel, basel-country.

Who invested in NBE Therapeutics?

NBE Therapeutics has 13 investors including Geekdom Fund And Geekdom Fund.

How much funding has NBE Therapeutics raised to date?

NBE Therapeutics has raised ____.

When was the last funding round for NBE Therapeutics?

NBE Therapeutics closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

nbe-therapeutics.com

NBE Therapeutics

NBE Therapeutics is a biotechnology company that develops and commercializes antibody-drug conjugates for the treatment of cancer.

Business Model:

Revenue: $9.6M

Employees: 51-200

NBE Therapeutics was acquired by Boehringer Ingelheim.
The acquisition happend on 2020-12-10.
Details of the transaction were not public

Acquirer

Boehringer Ingelheim

General Information

Geographic Data

Address: Hochbergerstrasse 60C

City: Basel

State: basel-country

Zip: 4057

Country: CH

Financial Info

Stage:

series c

Raised Last:

$22M

Raised Total:

$66M

Social

Crunchbase

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

NBE Therapeutics is a biotechnology company that develops and commercializes antibody-drug conjugates for the treatment of cancer.

Contact Phone:

Contact Email:

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
6/2018	Series B		$0	Boehringer Ingelheim Venture Fund Novo Holdings PPF Group Boehringer Ingelheim Venture Fund Novo Holdings PPF Group
3/2015	Series A		$3.1M	Boehringer Ingelheim Venture Fund
11/2016	Series B	2	$20.5M	Boehringer Ingelheim Venture Fund PPF Group PPF Group Boehringer Ingelheim Venture Fund PPF Group PPF Group
3/2015	Series A	1	$3.1M	Boehringer Ingelheim Venture Fund Boehringer Ingelheim Venture Fund Boehringer Ingelheim Venture Fund Boehringer Ingelheim Venture Fund
1/2013	Seed Round	1	-	Boehringer Ingelheim Venture Fund Boehringer Ingelheim Venture Fund Boehringer Ingelheim Venture Fund Boehringer Ingelheim Venture Fund
1/2020	Series C		$0	Boehringer Ingelheim PPF Group Boehringer Ingelheim PPF Group
6/2018	Series B		$20M	PPF Group Boehringer Ingelheim Venture Fund Novo Holdings A/S
1/2016	Grant		$1.1M
1/2020	Series C	2	$22M	Boehringer Ingelheim Venture Fund PPF Group Boehringer Ingelheim PPF Group
11/2016	Series B		$20M	PPF Group Boehringer Ingelheim Venture Fund PPF Group Boehringer Ingelheim Venture Fund
6/2018	Series B	3	$20M	Boehringer Ingelheim Venture Fund Novo Holdings PPF Group Boehringer Ingelheim Venture Fund Novo Holdings PPF Group
1/2013	Seed Round	1	-	Boehringer Ingelheim Venture Fund Boehringer Ingelheim Venture Fund Boehringer Ingelheim Venture Fund Boehringer Ingelheim Venture Fund

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details